Learn More
BACKGROUND AND OBJECTIVE High-dose chemotherapy and autologous bone marrow transplantation (ABMT) has become the standard approach for most patients with relapsed or refractory Hodgkin's disease.(More)
BACKGROUND AND OBJECTIVES In addition to anti-D alloantibody, other antibodies such as anti-K antibody and anti-PP1Pk antibody have been reported to cause severe haemolytic disease of the newborn(More)
  • 1